LONDON, January 16, 2019 /PRNewswire/ --
Global Bioreactors Market 2019-2029
5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
The global bioreactors market is expected to grow at a CAGR of 7.5% in the second half of the forecast period. In 2017, the single-use bioreactors segment held the largest share in the global bioreactors market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 163-page report you will receive 163 charts- all unavailable elsewhere.
The 163-page report provides clear detailed insight into the global bioreactors market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Bioreactor market forecasts from 2019-2029
• This report also breaks down the revenue forecast for the global bioreactor market by type of material:
• Glass
• Stainless-Steel
• Single-Use Bioreactors
Each submarket is further broken down by region: North America, Europe, Asia-Pacific and ROW.
• This report also breaks down the revenue forecast for the global bioreactor market by scale:
• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L
Each submarket is further broken down by region: North America, Europe, Asia-Pacific and ROW.
• This report also breaks down the revenue forecast for the global bioreactor market by usage:
• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production
Each submarket is further broken down by region: North America, Europe, Asia-Pacific and ROW.
• This report also breaks down the revenue forecast for the global bioreactor market by end-user:
• R&D Departments
• Biopharmaceutical Manufacturers
• Contract Research Organizations
• Other End-Users
Each submarket is further broken down by region: North America, Europe, Asia-Pacific and ROW.
• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US and rest of North America
• Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe
• Asia-Pacific: China, India, Japan, and rest of Asia-Pacific countries
• Rest of the World: Latin America, Middle East and African countries
Each region is further broken down by type of material, usage, scale and end-user.
• Our study gives qualitative analysis of the bioreactors market. It discusses the Drivers and Restraints that influence this market as well as the Porter's Five Forces Analysis of the bioreactors market.
• Our study discusses the selected leading companies that are the major players in the bioreactors industry:
• Applikon Biotechnology Inc. (U.S.)
• BBI-Biotech GmbH (Germany)
• Bioengineering AG (Switzerland)
• Danaher Corporation (U.S)
• Eppendorf AG (Germany)
• GE Healthcare (A subsidiary of General Electric Company) (U.S.)
• Merck KGaA (Germany)
• Sartorius AG (Germany)
• Solaris Biotech (Italy)
• Thermo Fisher Scientific, Inc. (U.S.)
Visiongain's study is intended for anyone requiring commercial analyses for the global bioreactors market. You find data, trends and predictions.
Buy our report today Global Bioreactors Market 2019-2029: 5L-20L, 20L-200L, 200L-1500L, Above 1500L, Single-Use, Glass, Stainless Steel, Lab-Scale, Pilot-Scale, Full-Scale, R&D Departments, Biopharmaceutical Manufacturers, Contract Research Organizations, Other End-Users.
To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-bioreactors-market-2019-2029/
Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.
Association of Clinical Research Organizations
Applikon Biotechnology Inc.
BBI-Biotech GmbH
Bioengineering AG
Danaher Corporation
EMD Performance Materials
EMD Serono
Eppendorf AG
Essen BioScience Inc.
Food and Drug Administration (FDA)
GE Healthcare
GEA Pharma Systems
G-CON Manufacturing
Merck KGaA
Merck Serono
Merck Millipore
MilliporeSigma
National Institute of Health and Care Excellence (NICE)
Pall Corporation
Pfizer
RoosterBio Inc
Sartorius AG
Solaris Biotech
Thermo Fisher Scientific Inc.
Xcellerex, Inc.
To see a report overview please e-mail Sara Peerun on [email protected]
SOURCE Visiongain
Share this article